Biofilm and planktonic pneumococci demonstrate disparate immunoreactivity to human convalescent sera

BMC Microbiology

Volumn 11, Issue , 2011, Pages

  Sanchez, Carlos J ^a   Hurtgen, Brady J ^a,b   Lizcano, Anel ^a   Shivshankar, Pooja ^a   Cole, Garry T ^b   Orihuela, Carlos J ^a  

^a University of Texas Health Science Center   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BACTERIAL PROTEIN; GENE PRODUCT; PNEUMOCOCCAL SERINE RICH REPEAT PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; PROTEOME;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL CELL; BACTERIAL CELL WALL; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; BIOFILM; CELL LYSATE; CROSS REACTION; DNA BINDING; ENERGY METABOLISM; HUMAN; HUMAN CONVALESCENT SERUM; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOREACTIVITY; INFECTION SENSITIVITY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; PLANKTON; PLANKTONIC PNEUMOCOCCI; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; REGULATORY MECHANISM; SEROTYPE; SERUM; STREPTOCOCCUS PNEUMONIAE; ANIMAL; BAGG ALBINO MOUSE; BLOOD; FEMALE; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; NASOPHARYNX; PHENOTYPE; PNEUMOCOCCAL INFECTION;

MUS; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BIOFILMS; FEMALE; HUMANS; IMMUNITY, HUMORAL; MICE; MICE, INBRED BALB C; NASOPHARYNX; PHENOTYPE; PNEUMOCOCCAL INFECTIONS; PROTEOME; STREPTOCOCCUS PNEUMONIAE;

EID: 80055118611     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-11-245     Document Type: Article

References (45)

1. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. Lexau CA, Lynfield R, Danila R, Pilishvili T, Facklam R, Farley MM, Harrison LH, Schaffner W, Reingold A, Bennett NM, Hadler J, Cieslak PR, Whitney CG, for the Active Bacterial Core Surveillance Team, JAMA 2005 294 16 2043 2051 10.1001/jama.294.16.2043 16249418 (Pubitemid 41539937)
2. Nasopharyngeal carriage of pneumococci in children with sickle cell disease. Overturf GD, Field R, Lam C, Lee S, Powars DR, Infect Immun 1980 28 3 1048 1050 7399687 (Pubitemid 10122543)
3. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Kadioglu A, Weiser JN, Paton JC, Andrew PW, Nat Rev Microbiol 2008 6 4 288 301 10.1038/nrmicro1871 18340341 (Pubitemid 351404773)
4. The pneumococcus: why a commensal misbehaves. Weiser JN, J Mol Med (Berl) 2010 88 2 97 102
5. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T, Lancet 2009 374 9693 893 902 10.1016/S0140-6736(09)61204-6 19748398
6. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. Roush SW, Murphy TV, JAMA 2007 298 18 2155 2163 10.1001/jama.298.18.2155 18000199 (Pubitemid 350106654)
7. Community-acquired pneumonia and nursing home-acquired pneumonia in the very elderly patients. Maruyama T, Gabazza EC, Morser J, Takagi T, D'Alessandro-Gabazza C, Hirohata S, Nakayama S, Ramirez AY, Fujiwara A, Naito M, Nishikubo K, Yuda H, Yoshida M, Takei Y, Taguchi O, Respir Med 2010 104 4 584 592 10.1016/j.rmed.2009.12.008 20060700
8. Demonstration of nasopharyngeal and middle ear mucosal biofilms in an animal model of acute otitis media. Hoa M, Syamal M, Sachdeva L, Berk R, Coticchia J, Ann Otol Rhinol Laryngol 2009 118 4 292 298 19462851
9. Identification of adenoid biofilms with middle ear pathogens in otitis-prone children utilizing SEM and FISH. Hoa M, Tomovic S, Nistico L, Hall-Stoodley L, Stoodley P, Sachdeva L, Berk R, Coticchia JM, Int J Pediatr Otorhinolaryngol 2009 73 9 1242 1248 10.1016/j.ijporl.2009.05.016 19525016
10. Opening plugged tympanostomy tubes: effect of biofilm formation. Mehta AJ, Lee JC, Stevens GR, Antonelli PJ, Otolaryngol Head Neck Surg 2006 134 1 121 125 10.1016/j.otohns.2005.10.017 16399191 (Pubitemid 43042323)
11. Adenoid reservoir for pathogenic biofilm bacteria. Nistico L, Kreft R, Gieseke A, Coticchia JM, Burrows A, Khampang P, Liu Y, Kerschner JE, Post JC, Lonergan S, Sampath R, Hu FZ, Ehrlich GD, Stoodley P, Hall-Stoodley L, J Clin Microbiol 2010 49 4 1411 1420
12. Streptococcus pneumoniae Forms Surface-Attached Communities in the Middle Ear of Experimentally Infected Chinchillas. Reid SD, Hong W, Dew KE, Winn DR, Pang B, Watt J, Glover DT, Hollingshead SK, Swords WE, J Infect Dis 2009
13. Bacterial biofilms on the sinus mucosa of human subjects with chronic rhinosinusitis. Sanderson AR, Leid JG, Hunsaker D, Laryngoscope 2006 116 7 1121 1126 10.1097/01.mlg.0000221954.05467.54 16826045 (Pubitemid 44317935)
14. The Pneumococcal serine-rich repeat protein is an intra-species bacterial adhesin that promotes bacterial aggregation in vivo and in biofilms. Sanchez CJ, Shivshankar P, Stol K, Trakhtenbroit S, Sullam PM, Sauer K, Hermans PW, Orihuela CJ, PLoS Pathog 2010 6 8
15. Microbial biofilms. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM, Annu Rev Microbiol 1995 49 711 745 10.1146/annurev.mi.49. 100195.003431 8561477
16. Bacterial biofilms: a common cause of persistent infections. Costerton JW, Stewart PS, Greenberg EP, Science 1999 284 5418 1318 1322 10.1126/science.284.5418.1318 10334980 (Pubitemid 29289651)
17. Characterization of biofilm matrix, degradation by DNase treatment and evidence of capsule downregulation in Streptococcus pneumoniae clinical isolates. Hall-Stoodley L, Nistico L, Sambanthamoorthy K, Dice B, Nguyen D, Mershon WJ, Johnson C, Hu FZ, Stoodley P, Ehrlich GD, Post JC, BMC Microbiol 2008 8 173 10.1186/1471-2180-8-173 18842140
18. Biofilms: survival mechanisms of clinically relevant microorganisms. Donlan RM, Costerton JW, Clin Microbiol Rev 2002 15 2 167 193 10.1128/CMR.15.2.167-193.2002 11932229 (Pubitemid 34303762)
19. Differences in biofilm development and antibiotic susceptibility among Streptococcus pneumoniae isolates from cystic fibrosis samples and blood cultures. Garcia-Castillo M, Morosini MI, Valverde A, Almaraz F, Baquero F, Canton R, del Campo R, J Antimicrob Chemother 2007 59 2 301 304 17142818 (Pubitemid 47072071)
20. Mechanisms of antibiotic resistance in bacterial biofilms. Stewart PS, Int J Med Microbiol 2002 292 2 107 113 10.1078/1438-4221-00196 12195733 (Pubitemid 34842181)
21. Antibiotic resistance of bacteria in biofilms. Stewart PS, Costerton JW, Lancet 2001 358 9276 135 138 10.1016/S0140-6736(01)05321-1 11463434 (Pubitemid 32709857)
22. Streptococcus pneumoniae is desiccation tolerant and infectious upon rehydration. Walsh RL, Camilli A, MBio 2011 2 3 00092 00011 21610120
23. Isolation of Streptococcus pneumoniae biofilm mutants and their characterization during nasopharyngeal colonization. Munoz-Elias EJ, Marcano J, Camilli A, Infect Immun 2008 76 11 5049 5061 10.1128/IAI.00425-08 18794289
24. Phenotypic characterization of Streptococcus pneumoniae biofilm development. Allegrucci M, Hu FZ, Shen K, Hayes J, Ehrlich GD, Post JC, Sauer K, J Bacteriol 2006 188 7 2325 2335 10.1128/JB.188.7.2325-2335.2006 16547018
25. Switch from planktonic to sessile life: a major event in pneumococcal pathogenesis. Oggioni MR, Trappetti C, Kadioglu A, Cassone M, Iannelli F, Ricci S, Andrew PW, Pozzi G, Mol Microbiol 2006 61 5 1196 1210 10.1111/j.1365-2958. 2006.05310.x 16925554 (Pubitemid 44215421)
26. Cellular senescence increases expression of bacterial ligands in the lungs and is positively correlated with increased susceptibility to pneumococcal pneumonia. Shivshankar P, Boyd AR, Le Saux CJ, Yeh IT, Orihuela CJ, Aging Cell 2011
27. The Streptococcus pneumoniae adhesin PsrP binds to Keratin 10 on lung cells. Shivshankar P, Sanchez C, Rose LF, Orihuela CJ, Mol Microbiol 2009 73 4 663 679 10.1111/j.1365-2958.2009.06796.x 19627498
28. Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models. Orihuela CJ, Mahdavi J, Thornton J, Mann B, Wooldridge KG, Abouseada N, Oldfield NJ, Self T, Ala'Aldeen DA, Tuomanen EI, J Clin Invest 2009 119 6 1638 1646 10.1172/JCI36759 19436113
29. The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Zhang JR, Mostov KE, Lamm ME, Nanno M, Shimida S, Ohwaki M, Tuomanen E, Cell 2000 102 6 827 837 10.1016/S0092-8674(00) 00071-4 11030626
30. Biofilm formation by Streptococcus pneumoniae: role of choline, extracellular DNA, and capsular polysaccharide in microbial accretion. Moscoso M, Garcia E, Lopez R, J Bacteriol 2006 188 22 7785 7795 10.1128/JB.00673-06 16936041 (Pubitemid 44764515)
31. Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae. Tu AH, Fulgham RL, McCrory MA, Briles DE, Szalai AJ, Infect Immun 1999 67 9 4720 4724 10456922 (Pubitemid 29400455)
32. Differentially expressed proteins of gamma-ray irradiated mouse intestinal epithelial cells by two-dimensional electrophoresis and MALDI-TOF mass spectrometry. Zhang B, Su YP, Ai GP, Liu XH, Wang FC, Cheng TM, World J Gastroenterol 2003 9 12 2726 2731 14669322 (Pubitemid 38054449)
33. Contribution of serotype and genetic background to biofilm formation by Streptococcus pneumoniae. Camilli R, Pantosti A, Baldassarri L, Eur J Clin Microbiol Infect Dis 30 1 97 102
34. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. Hall-Stoodley L, Hu FZ, Gieseke A, Nistico L, Nguyen D, Hayes J, Forbes M, Greenberg DP, Dice B, Burrows A, Wackym PA, Stoodley P, Post JC, Ehrlich GD, Kerschner JE, JAMA 2006 296 2 202 211 10.1001/jama.296.2.202 16835426 (Pubitemid 44050374)
35. Pneumococcal biofilms. Moscoso M, Garcia E, Lopez R, Int Microbiol 2009 12 2 77 85 19784927
36. Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies. Giefing C, Meinke AL, Hanner M, Henics T, Bui MD, Gelbmann D, Lundberg U, Senn BM, Schunn M, Habel A, Henriques-Normark B, Ortqvist A, Kalin M, von Gabain A, Nagy E, J Exp Med 2008 205 1 117 131 10.1084/jem.20071168 18166586 (Pubitemid 351185720)
37. Antibodies against PsrP, a novel Streptococcus pneumoniae adhesin, block adhesion and protect mice against pneumococcal challenge. Rose L, Shivshankar P, Hinojosa E, Rodriguez A, Sanchez CJ, Orihuela CJ, J Infect Dis 2008 198 3 375 383 10.1086/589775 18507531
38. PsrP, a protective pneumococcal antigen, is highly prevalent in children with pneumonia and is strongly associated with clonal type. Munoz-Almagro C, Selva L, Sanchez CJ, Esteva C, de Sevilla MF, Pallares R, Orihuela CJ, Clin Vaccine Immunol 2010 17 11 1672 1678 10.1128/CVI.00271-10 20861332
39. Identification of Staphylococcus aureus proteins recognized by the antibody-mediated immune response to a biofilm infection. Brady RA, Leid JG, Camper AK, Costerton JW, Shirtliff ME, Infect Immun 2006 74 6 3415 3426 10.1128/IAI.00392-06 16714572 (Pubitemid 43794532)
40. Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse. Ling E, Feldman G, Portnoi M, Dagan R, Overweg K, Mulholland F, Chalifa-Caspi V, Wells J, Mizrachi-Nebenzahl Y, Clin Exp Immunol 2004 138 2 290 298 10.1111/j.1365-2249.2004.02628.x 15498039 (Pubitemid 39472446)
41. alpha-Enolase of Streptococcus pneumoniae is a plasmin(ogen)-binding protein displayed on the bacterial cell surface. Bergmann S, Rohde M, Chhatwal GS, Hammerschmidt S, Mol Microbiol 2001 40 6 1273 1287 10.1046/j.1365-2958.2001. 02448.x 11442827 (Pubitemid 32635298)
42. Flamingo cadherin: a putative host receptor for Streptococcus pneumoniae. Blau K, Portnoi M, Shagan M, Kaganovich A, Rom S, Kafka D, Chalifa Caspi V, Porgador A, Givon-Lavi N, Gershoni JM, Dagan R, Mizrachi Nebenzahl Y, J Infect Dis 2007 195 12 1828 1837 10.1086/518038 17492599 (Pubitemid 46870256)
43. Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae. Ogunniyi AD, Grabowicz M, Briles DE, Cook J, Paton JC, Infect Immun 2007 75 1 350 357 10.1128/IAI.01103-06 17088353 (Pubitemid 46047911)
44. Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Tettelin H, Nelson KE, Paulsen IT, Eisen JA, Read TD, Peterson S, Heidelberg J, DeBoy RT, Haft DH, Dodson RJ, Durkin AS, Gwinn M, Kolonay JF, Nelson WC, Peterson JD, Umayam LA, White O, Salzberg SL, Lewis MR, Radune D, Holtzapple E, Khouri H, Wolf AM, Utterback TR, Hansen CL, McDonald LA, Feldblyum TV, Angiuoli S, Dickinson T, Hickey EK, et al. Science 2001 293 5529 498 506 10.1126/science.1061217 11463916 (Pubitemid 32679078)
45. High resolution two-dimensional electrophoresis of proteins. O'Farrell PH, J Biol Chem 1975 250 10 4007 4021 236308